Cancer Research UK and EPSRC Cancer Imaging Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust

Facilities in the Cancer Research UK and EPSRC Cancer Imaging Centre include two clinical 1.5-T MR scanners, a 3T clinical scanner, together with 7-T and 11.7-T experimental systems. The primary research focus is on defining the role of magnetic resonance (MR) in cancer diagnosis, staging, and response assessment. Functional MR methods are being developed and evaluated as prognostic and therapeutic biomarkers particularly for determining the action of and response to novel therapeutic agents. These approaches are increasingly using quantitative imaging and spectroscopy methodologies. The Section is also developing and assessing MR methods for radiotherapy planning, developing improved analysis for breast cancer and exploring basic technologies such as dynamic nuclear polarisation. The Section has provided analysis methods to academic centres and industry and has reported methods in cancer staging and screening that have led practice and provided national guidelines.